What can we learn about schizophrenia from studying the human model, drug-induced psychosis?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
What can we learn about schizophrenia from studying the human model, drug-induced psychosis?
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
Volume 162, Issue 7, Pages 661-670
Publisher
Wiley
Online
2013-10-17
DOI
10.1002/ajmg.b.32177
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
- (2013) Arsime Demjaha et al. BIOLOGICAL PSYCHIATRY
- Substance-Induced Psychoses Converting Into Schizophrenia
- (2013) Jussi A. Niemi-Pynttäri et al. JOURNAL OF CLINICAL PSYCHIATRY
- Dose-Related Psychotic Symptoms in Chronic Methamphetamine Users
- (2013) Rebecca McKetin et al. JAMA Psychiatry
- Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users
- (2012) Marta Di Forti et al. BIOLOGICAL PSYCHIATRY
- Khat use among Somali mental health service users in South London
- (2012) Alex D. Tulloch et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- Ketamine use: a review
- (2011) Celia J. A. Morgan et al. ADDICTION
- Cannabis, COMT and psychotic experiences
- (2011) Stanley Zammit et al. BRITISH JOURNAL OF PSYCHIATRY
- Synthetic cannabinoid JWH-018 and psychosis: An explorative study
- (2011) Susanna Every-Palmer DRUG AND ALCOHOL DEPENDENCE
- Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort
- (2011) E. Manrique-Garcia et al. PSYCHOLOGICAL MEDICINE
- Remission of Persistent Methamphetamine-Induced Psychosis After Electroconvulsive Therapy: Presentation of a Case and Review of the Literature
- (2010) David J. Grelotti et al. AMERICAN JOURNAL OF PSYCHIATRY
- Decreased Frontal Serotonin2A Receptor Binding in Antipsychotic-Naive Patients With First-Episode Schizophrenia
- (2010) Hans Rasmussen et al. ARCHIVES OF GENERAL PSYCHIATRY
- Association Between Cannabis Use and Psychosis-Related Outcomes Using Sibling Pair Analysis in a Cohort of Young Adults
- (2010) John McGrath et al. ARCHIVES OF GENERAL PSYCHIATRY
- Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of CannabisSibling Analysis and Proband Follow-upGenetic Variation Underlying Cannabis Effects
- (2010) Ruud van Winkel ARCHIVES OF GENERAL PSYCHIATRY
- Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study
- (2010) Emma Barkus et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The environment and schizophrenia
- (2010) Jim van Os et al. NATURE
- Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge
- (2010) Paul R.A. Stokes et al. NEUROIMAGE
- Legal Highs on the Internet
- (2010) Jennifer Hillebrand et al. SUBSTANCE USE & MISUSE
- Genetic association studies of methamphetamine use disorders: A systematic review and synthesis
- (2009) Chad A. Bousman et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- High-potency cannabis and the risk of psychosis
- (2009) Marta Di Forti et al. BRITISH JOURNAL OF PSYCHIATRY
- S39-02 Antipsychotic effects of cannabidiol
- (2009) F.M. Leweke et al. EUROPEAN PSYCHIATRY
- ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?
- (2009) Volker Auwärter et al. JOURNAL OF MASS SPECTROMETRY
- Pharmacodynamic and pharmacokinetic effects of the intravenous CB1 receptor agonist Org 26828 in healthy male volunteers
- (2009) L Zuurman et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Can recreational doses of THC produce significant dopamine release in the human striatum?
- (2009) Paul R.A. Stokes et al. NEUROIMAGE
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
- (2009) P. D. Morrison et al. PSYCHOLOGICAL MEDICINE
- The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms?
- (2009) Daria Peleg-Raibstein et al. PSYCHOPHARMACOLOGY
- Psychedelics and schizophrenia
- (2009) Javier González-Maeso et al. TRENDS IN NEUROSCIENCES
- Prevalence of psychotic symptoms in substance users: a comparison across substances
- (2008) Matthew J. Smith et al. COMPREHENSIVE PSYCHIATRY
- Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity
- (2008) Louise Adermark et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Schizophrenia: From developmental deviance to dopamine dysregulation
- (2008) Robin M. Murray et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Potency of Δ9–THC and Other Cannabinoids in Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology
- (2008) David J. Potter et al. JOURNAL OF FORENSIC SCIENCES
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Striatal Plasticity and Basal Ganglia Circuit Function
- (2008) Anatol C. Kreitzer et al. NEURON
- Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
- (2008) Matthijs G Bossong et al. NEUROPSYCHOPHARMACOLOGY
- The CB1 cannabinoid receptor antagonist AM251 attenuates amphetamine-induced behavioural sensitization while causing monoamine changes in nucleus accumbens and hippocampus
- (2008) Gunnar Thiemann et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Gene-Environment Interactions in Schizophrenia: Review of Epidemiological Findings and Future Directions
- (2008) J. van Os et al. SCHIZOPHRENIA BULLETIN
- The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization
- (2007) G THIEMANN et al. BEHAVIOURAL BRAIN RESEARCH
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started